Skip to main content
Professionals

Please explore the resources below and the the "More Filters" button below to find specific resources in your search. The documents in this section include Guidelines, Publications, Presentations, Videos and Papers for specific Conditions and Procedures.

Find a guideline or consensus statement Click Here
Audience




Type
















Conditions


































Procedures












Other










Back to Categories

Results in 'Consensus Statements and Guidelines' and 'Crohn's Disease'

ECCO guidelines on therapeutics disease in Crohn’s disease: Surgical treatment (2019)

2 May 2022
Consensus Statements and Guidelines

This article is the second in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn’s disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn’s disease and an update of previous guidelines.

ECCO guidelines on therapeutics disease in Crohn’s disease: Medical treatment (2019)

2 May 2022
Consensus Statements and Guidelines

Crohn’s disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in progressive bowel damage and disability.1 CD can affect individuals of any age, from children to the elderly,2,3 and may cause significant morbidity and impact on quality of life. Up to one-third of patients present with complicated behaviour [strictures, fistula, or abscesses] at diagnosis.4 Most patients over time will develop a complication, with roughly 50% of patients requiring surgery within 10 years of diagnosis.5–7 As the precise aetiology of CD remains unknown, a curative therapy is not yet available.8 Several agents are available for the medical treatment of CD. Medical agents include mesalazine [5-ASA], locally active steroids [such as budesonide], systemic steroids, thiopurines such as azathioprine [AZA] and mercaptopurine [MP], methotrexate [MTX], and biologic therapies (such as anti-tumour necrosis factor [TNF], anti-integrins, and anti-interleukin [IL] 12/23].

The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery

16 August 2021
Consensus Statements and Guidelines

There is a requirement for an expansive and up to date review of the management of emergency colorectal conditions seen in adults. The primary objective is to provide detailed evidence-based guidelines for the target audience of general and colorectal surgeons who are responsible for an adult population and who practise in Great Britain and Ireland.

BSG guidelines on inflammatory bowel disease biopsies

3 August 2021
Consensus Statements and Guidelines

The British Society of Gastroenterology

3 August 2021
Consensus Statements and Guidelines

BSG guidelines on inflammatory bowel disease biopsies

9 June 2021
Consensus Statements and Guidelines

Roles descriptives for inflammatory bowel disease nurse specialists

25 January 2016
Consensus Statements and Guidelines

Royal College of Nursing (RCN), 2007

ACPGBI Position Statements: Management of Anal Fissure and Management of Acute Severe Colitis

26 October 2012
ACPGBI Publications
Consensus Statements and Guidelines

These position statements were published as a Colorectal Disease supplement to Volume 9 in 2007.